EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Harnessing Noncanonical Proteins for Next‐Generation Drug Discovery and Diagnosis

Nachiket Rajinikanth iD, Ruchi Chauhan, Sudhakaran Prabakaran iD

WIREs Mechanisms of Disease · 2025-05 · 17 (3)

DOI: 10.1002/wsbm.70001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift WIREs Mechanisms of Disease, online erschienen am 27.05.2025. Verfasst von Nachiket Rajinikanth und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA. Hauptthemen laut MEDLINE: Drug Discovery, Proteome, Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Noncanonical proteins, encoded by previously overlooked genomic regions (part of the “dark genome”), are emerging as crucial players in human health and disease, expanding our understanding of the “dark proteome.” This review explores their landscape, including proteins derived from long non‐coding RNAs, circular RNAs, and alternative open reading frames. Recent advances in ribosome profiling, mass spectrometry, and proteogenomics have unveiled their involvement in critical cellular processes. We examine their roles in cancer, neurological disorders, cardiovascular diseases, and infectious diseases, highlighting their potential as novel biomarkers and therapeutic targets. The review addresses challenges in identifying and characterizing these proteins, particularly recently evolved ones, and discusses implications for drug discovery, including cancer immunotherapy and neoantigen sources. By synthesizing recent findings, we underscore the significance of noncanonical proteins in expanding our understanding of the human genome and proteome, and their promise in developing innovative diagnostic tools and targeted therapies. This overview aims to stimulate further research into this unexplored biological space, potentially revolutionizing approaches to disease treatment and personalized medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryProteomeProteinsHumansNeoplasmsAnimalsRNA, Long NoncodingRNA, CircularPrecision MedicineProteomicsBiomarkers

Stichwörter der Autor:innen

alternative open reading framesdark genomedark proteomeneoantigensnoncanonical proteinsnovel cancer biomarkersnovel drug discoverynovel psychiatry biomarkersproteogenomicsribosome profiling

Substanzen

ProteomeRNA, Long NoncodingRNA, CircularProteinsBiomarkers

Autor:innen und Institutionen

  • University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA.
  • NonExomics, Inc., Acton, Massachusetts, USA.
  • Northeastern University, Boston, Massachusetts, USA.

ORCID-Profile: Nachiket Rajinikanth, Sudhakaran Prabakaran

Zitieren

APA

Rajinikanth, N., Chauhan, R., & Prabakaran, S. (2025). Harnessing Noncanonical Proteins for Next‐Generation Drug Discovery and Diagnosis. WIREs Mechanisms of Disease, 17(3). https://doi.org/10.1002/wsbm.70001

Vancouver

Rajinikanth N, Chauhan R, Prabakaran S. Harnessing Noncanonical Proteins for Next‐Generation Drug Discovery and Diagnosis. WIREs Mechanisms of Disease. 2025;17(3). doi:10.1002/wsbm.70001

BibTeX
@article{Rajinikanth2025,
  author = {Rajinikanth, Nachiket and Chauhan, Ruchi and Prabakaran, Sudhakaran},
  title = {Harnessing Noncanonical Proteins for Next‐Generation Drug Discovery and Diagnosis},
  journal = {WIREs Mechanisms of Disease},
  year = {2025},
  volume = {17},
  number = {3},
  doi = {10.1002/wsbm.70001}
}
Kostenlos starten →